Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Intervalo de ano de publicação
2.
Gastroenterol Hepatol ; 41(5): 315-317, 2018 May.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28716492
5.
Rev. esp. geriatr. gerontol. (Ed. impr.) ; 47(3): 110-113, mayo-jun. 2012.
Artigo em Espanhol | IBECS | ID: ibc-100331

RESUMO

Objetivos. Analizar las características al ingreso, el curso evolutivo y el pronóstico de la hemorragia digestiva alta (HDA) en el paciente anciano. Material y métodos. Estudio prospectivo en el que se incluyeron 103 pacientes con edad igual o superior a 80 años, que ingresaron en una Unidad de Sangrantes por un episodio de HDA en un año. Analizamos los antecedentes personales, características de la hemorragia, realización de la endoscopia urgente diagnóstica y terapéutica y factores pronósticos asociados. Resultados. La etiología más frecuente de la HDA fue el sangrado por úlcera gastroduodenal en el 65,1%, siendo el 60,2% consumidores crónicos de antiinflamatorios no esteroideos. Se realizó endoscopia diagnóstica urgente en todos ellos, con una eficacia del 94,2% y terapéutica en el 28,2%. La tasa de resangrado fue del 8%, requiriendo cirugía urgente el 4,9%, con una mortalidad global del 5,8%. Conclusiones. La realización de endoscopia urgente y la aplicación de terapéutica endoscópica es un método seguro y eficaz para detener el sangrado por HDA en el anciano, lo cual ha reducido la necesidad de cirugía urgente, mejorando la supervivencia del enfermo anciano sangrante(AU)


Objectives. To evaluate the patient characteristics, outcome, and prognosis of upper gastrointestinal haemorrhage in the elderly. Material and methods. A prospective study was conducted on 103 patients aged 80 years and over, admitted to a Gastrointestinal Bleeding Unit after an episode of upper gastrointestinal bleeding. We analysed the personal history, the characteristics of the bleeding event, and whether an urgent diagnostic or therapeutic endoscopy was performed, in order to identify clinical data and endoscopic findings that may have an influence on the outcome of the haemorrhage. Results. The major cause of the haemorrhage was peptic ulcer in 65.1%, and 60.2% of patients were on chronic treatment with non-steroidal anti-inflammatory drugs. An urgent diagnostic endoscopy was performed in all of them, identifying the source of bleeding in 94.2%, and treatment was carried out on 28.2%. The likelihood of rebleeding was 8%, and 4.9% of patients underwent emergency surgery, with an overall mortality rate of 5.8%. Conclusions. The performance of urgent endoscopy and the application of endoscopic haemostasis are safe and effective in stopping upper gastrointestinal bleeding in the elderly. This has significantly reduced the need for emergency surgery, improving the survival of the bleeding elderly patient and preventing recurrent bleeding(AU)


Assuntos
Humanos , Masculino , Feminino , Idoso de 80 Anos ou mais , Hemorragia Gastrointestinal/epidemiologia , Úlcera Péptica/epidemiologia , Comorbidade , Hemorragia Gastrointestinal/complicações , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/terapia , Úlcera Péptica/complicações , Úlcera Péptica/prevenção & controle , Endoscopia/métodos , Endoscopia/tendências , Endoscopia , Estudos Prospectivos , Valor Preditivo dos Testes
6.
Rev Esp Geriatr Gerontol ; 47(3): 110-3, 2012.
Artigo em Espanhol | MEDLINE | ID: mdl-22100218

RESUMO

OBJECTIVES: To evaluate the patient characteristics, outcome, and prognosis of upper gastrointestinal haemorrhage in the elderly. MATERIAL AND METHODS: A prospective study was conducted on 103 patients aged 80 years and over, admitted to a Gastrointestinal Bleeding Unit after an episode of upper gastrointestinal bleeding. We analysed the personal history, the characteristics of the bleeding event, and whether an urgent diagnostic or therapeutic endoscopy was performed, in order to identify clinical data and endoscopic findings that may have an influence on the outcome of the haemorrhage. RESULTS: The major cause of the haemorrhage was peptic ulcer in 65.1%, and 60.2% of patients were on chronic treatment with non-steroidal anti-inflammatory drugs. An urgent diagnostic endoscopy was performed in all of them, identifying the source of bleeding in 94.2%, and treatment was carried out on 28.2%. The likelihood of rebleeding was 8%, and 4.9% of patients underwent emergency surgery, with an overall mortality rate of 5.8%. CONCLUSIONS: The performance of urgent endoscopy and the application of endoscopic haemostasis are safe and effective in stopping upper gastrointestinal bleeding in the elderly. This has significantly reduced the need for emergency surgery, improving the survival of the bleeding elderly patient and preventing recurrent bleeding.


Assuntos
Hemorragia Gastrointestinal , Idoso de 80 Anos ou mais , Feminino , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/terapia , Humanos , Masculino , Prognóstico , Estudos Prospectivos
8.
Gastroenterol. hepatol. (Ed. impr.) ; 33(6): 433-435, Jun. -Jul. 2010. ilus
Artigo em Espanhol | IBECS | ID: ibc-84832

RESUMO

En el curso de la enfermedad inflamatoria intestinal pueden aparecer múltiples manifestaciones extraintestinales, y las cutáneas son bastante habituales tanto en la colitis ulcerosa como en la enfermedad de Crohn. El pioderma gangrenoso y el eritema nodoso son las más frecuentes, y existen otras manifestaciones cutáneas muy poco frecuentes, como la vasculitis leucocitoclástica. Presentamos el caso de un paciente en el que se diagnosticó de forma simultánea la enfermedad de Crohn y la vasculitis cutánea, con mejoría clínica significativa de ambos cuadros tras instaurar tratamiento con corticoides (AU)


In the course of inflammatory bowel disease (IBD) a number of extraintestinal manifestations are known to occur, being the dermatological ones often associated to both ulcerative colitis and Crohn's disease. Pyoderma gangrenosum and erythema nodosum are the most frequent, but there are other skin manifestations less frequently reported such as leukocytoclastic vasculitis. We present a case, in which Crohn's disease and leukocytoclastic vasculitis were simultaneously diagnosed, and corticoids treatment achieved complete remission of the both cutaneous and gastrointestinal manifestations (AU)


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Doença de Crohn/complicações , Vitamina D/uso terapêutico , Complicações do Diabetes , Dieta com Restrição de Proteínas , Quimioterapia Combinada , Endoscopia do Sistema Digestório , Nutrição Enteral , Heparina de Baixo Peso Molecular/uso terapêutico , Mesalamina/uso terapêutico , Prednisolona/uso terapêutico , Doença de Crohn/diagnóstico , Doença de Crohn/dietoterapia , Doença de Crohn/tratamento farmacológico , Doença de Crohn , Analgésicos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Cálcio/uso terapêutico , Terapia Combinada
9.
Gastroenterol Hepatol ; 33(6): 433-5, 2010.
Artigo em Espanhol | MEDLINE | ID: mdl-19818534

RESUMO

In the course of inflammatory bowel disease (IBD) a number of extraintestinal manifestations are known to occur, being the dermatological ones often associated to both ulcerative colitis and Crohn's disease. Pyoderma gangrenosum and erythema nodosum are the most frequent, but there are other skin manifestations less frequently reported such as leukocytoclastic vasculitis. We present a case, in which Crohn's disease and leukocytoclastic vasculitis were simultaneously diagnosed, and corticoids treatment achieved complete remission of the both cutaneous and gastrointestinal manifestations.


Assuntos
Doença de Crohn/complicações , Vasculite Leucocitoclástica Cutânea/complicações , Analgésicos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Cálcio/uso terapêutico , Terapia Combinada , Doença de Crohn/diagnóstico , Doença de Crohn/diagnóstico por imagem , Doença de Crohn/dietoterapia , Doença de Crohn/tratamento farmacológico , Complicações do Diabetes , Dieta com Restrição de Proteínas , Quimioterapia Combinada , Endoscopia do Sistema Digestório , Nutrição Enteral , Heparina de Baixo Peso Molecular/uso terapêutico , Humanos , Masculino , Mesalamina/uso terapêutico , Pessoa de Meia-Idade , Prednisolona/uso terapêutico , Ultrassonografia , Vasculite Leucocitoclástica Cutânea/diagnóstico , Vasculite Leucocitoclástica Cutânea/tratamento farmacológico , Vitamina D/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...